| Skating to where the puck was - rather than where it is going to be - is called "performance chasing" in the investment world. Twenty-three years ago, investors chased dot-com stocks. They crashed and burned. A decade later they rushed to make furious above-market bids on residential real estate. The property market imploded. (And there is good evidence that another property bubble is developing today.) Crypto speculators - I refuse to call them "investors" - chased Bitcoin and other digital currencies into the stratosphere. Now most are sitting on big losses. Over a year ago, investors fell in love with "disruptive" tech companies that were not only pre-earnings but pre-revenue. Result? Cathie Wood's Ark Innovation ETF (ARKK) - a good proxy for the "no price is too high to pay" approach to investing - fell from grace. These investors all ignored Gretzky's sage advice. They skated to where the puck had been rather than where it was going to be. This is a perennial problem. Today, for example, most investors are chasing the same small group of "value stocks," the new investment du jour that has outperformed the market in recent months. True, there is still some upside here. But Oxford Club Members picked up value stocks like CVS Health (CVS), Energy Select Sector SPDR Fund (XLE), Arch Capital (ACGL) and Berkshire Hathaway (BRK-B) more than a year ago. Now we're sitting on big profits and cashed out on others. We didn't buy them because they were in favor but precisely because they were out of favor. Want to skate now to where the puck will soon be? Then invest a few dollars in one of the most promising and undervalued sectors in the market right now: small cap medical technology. There are three good reasons to expect big returns here in the weeks and months ahead. - Healthcare is recession-resistant. It doesn't matter whether the economy is expanding or contracting, whether inflation is hotter or colder, or whether interest rates are rising or falling. People who need medical attention will seek it and find it. You can take economic forecasting off the table. The demand for medical services is largely inelastic.
- Innovation is constant. New medical devices are protecting, extending and saving our lives. Virtually all are patent protected. That stops competition, puts a moat around profit margins, and drives strong top- and bottom-line growth.
- It's the perfect contrarian investment. Technology stocks have been hit hard this year. But small cap tech stocks - including those in the medical field - are lying in the bargain bin, unloved and undervalued. And therein lies a huge opportunity.
YOUR ACTION PLAN I recently pinpointed a medical technology stock that has all the makings of a superb investment. In my latest presentation, I explain why medical technology is where the puck is going to be - and reveal the name (and ticker symbol) of one of the most exciting innovators in the sector. The only question Wayne Gretzky would ask at this point is "Will you take the shot?" Click here to discover this medical technology stock. Good investing, Alex | 
.jpg)
No comments:
Post a Comment